Nasdaq Marketscompaniesroutine announcement
A Vaxcyte Executive Just Cashed Options Struck at $5.35. Here's What Long-Term Investors Should Know (opens at Nasdaq Markets in a new tab)
A Vaxcyte executive cashed options struck at $5.35, with transactions totaling about $378,000 at a weighted average price of $61.12 per share. The filing shows an insider monetizing previously granted options.
